Date Filed | Type | Description |
03/17/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Paid exercise price by delivering 1,410 shares
@ $17.12, valued at
$24.1k
|
|
02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/27/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 8,336 shares
@ $21.07, valued at
$175.6k
|
|
01/19/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,126 shares
@ $18, valued at
$56.3k
|
|
01/05/2023 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,126 shares
@ $18.35, valued at
$57.4k
|
|
12/19/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,126 shares
@ $16, valued at
$50k
|
|
12/05/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,126 shares
@ $17.84, valued at
$55.8k
|
|
11/17/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,126 shares
@ $18.72, valued at
$58.5k
|
|
11/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/05/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,126 shares
@ $19.64, valued at
$61.4k
|
|
09/19/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 4,168 shares
@ $21.01, valued at
$87.6k
|
|
09/09/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 1,042 shares
@ $21.0017, valued at
$21.9k
|
|
09/06/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Acquired 1,336 shares
@ $11.02, valued at
$14.7k
Sold 3,126 shares
@ $18.59, valued at
$58.1k
|
|
05/04/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,247 shares
@ $20.096, valued at
$65.3k
|
|
04/21/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 5,664 shares
@ $25.81, valued at
$146.2k
|
|
04/06/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 9,000 shares
@ $23.9735, valued at
$215.8k
|
|
04/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,123 shares
@ $18.64, valued at
$58.2k
|
|
01/20/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 4,168 shares
@ $23.29, valued at
$97.1k
|
|
01/06/2022 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 7,168 shares
@ $28.02, valued at
$200.8k
|
|
12/30/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/17/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
11/17/2021 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 5,668 shares
@ $26.75, valued at
$151.6k
Sold 1,500 shares
@ $27.97, valued at
$42k
|
|
11/09/2021 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 12,600 shares
@ $27.952, valued at
$352.2k
Sold 3,900 shares
@ $28.422, valued at
$110.8k
|
|
11/03/2021 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 5,668 shares
@ $24.79, valued at
$140.5k
|
|
10/28/2021 |
4
| Betz Stephen F. (Chief Scientific Officer) has filed a Form 4 on Crinetics Pharmaceuticals, Inc.
Txns:
| Sold 3,000 shares
@ $23.997, valued at
$72k
|
|
10/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/19/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |